running order
08:00 - 09:30
Welcome Coffee - Exhibition Lounge
09:30 – 09:45
Grand Opening - Plenary Room
Laurette Onkelinx - Minister of Public Health and Social Affairs
09:45 – 10:45
"The Impatient Patient" - Plenary Room
Chair: Dr. Jo De Cock (General administrator National Institute of Health & Disability Insurance)
"Belgium's Patient Movement: Size and Scope" - Dr. Alexandra Wyke (Founder and CEO PatientView)
"Valuing Patient Involvement - A European Perspective" - Nicola Bedlington (Executive Director European Patients’ Forum)
10:45 – 11:15
Coffee break - Exhibition Lounge
11:15 – 12:30
The Initiative to Promote Clinical Trials in Belgium – Plenary Room
Chair : Dr. Greet Musch (General Director DG Pre-authorisation FAMHP)
- "Clinical Trials with Medical Devices" - David Bouchez (Clinical Program Manager Stentys, Consultant UNAMEC)
- "The Strategic Plan to Promote Clinical Trials in Belgium" - Ingrid Maes (Director Strategy & Operations Pharma & Healthcare PwC Belgium)
12:30 - 14:00
Lunch - Exhibition Lounge
14:00 - 16:00
Break-out parallel sessions
Patient Access to Medicines - BEAPP
Chair: Dr. Stefaan Vancayzeele (Vice-Chair BeAPP, CSO Novartis)
- "Clinical inertia, a major concern in drug therapy" - Prof. Dr. André Scheen (Head of the Division of Diabetes, Nutrition & Metabolic Disorders and of the Clinical Pharmacology Unit, CHU Liège)
- "Early access and market authorization" - Dr. Greet Musch (General Director DG Pre-authorisation FAMHP)
- "Unmet medical need and early access" - Dr. Ri De Ridder (Director General National Institute of Health & Disability Insurance)
Assessment of Medicines - pharma.be I
Chair : Richard Bergström (Director General EFPIA)
- "Scope of Health Technology Assessment: the 5y Perspective" - Prof. Dr. Bruno Flamion (Professor of Physiology and Pharmacology, University of Namur, Belgium, EMA, chairman CTG/CRM)
- "The progresses of WP5 and the objectives of the Working Group within the frame of the second Joint Action" - Sarah Kleijnen (Project Coordinator EUnetHTA WP5, College voor Zorgverzekeringen (CVZ))
Innovation in early clinical drug development – BAPU
Chair : Prof. Dr. Jan de Hoon (Head of the Center for Clinical Pharmacology (KULeuven/UZ Leuven), Chairman Belgian Association of Phase I Units (BAPU)) – Dr. Maikel Raghoebar (Senior Director, Head Clinical Pharmacology Unit Janssen in Belgium and Vice-Chair BAPU)
- "Welcome and introduction" - Dr. Maikel Raghoebar (Senior Director, Head Clinical Pharmacology Unit Janssen in Belgium and Vice-Chair BAPU)
- "Is there a need for a European registration system for subjects participating in clinical trials ?" - Annick Peremans (General Manager Research Centre Aalst, Belgium)
Mini-Symposium – "Imaging techniques as innovative biomarkers in the exploratory phase of clinical drug development"
- "Biomarkers : what’s in a name?" - Prof. Dr. Jan de Hoon
- "PET: a primary exploratory technology in rational drug development?" - Prof. Dr. Koen Van Laere (Clinical Head and University professor KULeuven)
- "Added value of functional MRI (fMRI)" - Prof. Dr. Rik Achten
- "Hybrid SPECT/CT imaging: the perfect marriage to explore new horizons" - Dr. Pieter De Bondt (Head Division Nuclear Medicine, OLV Hospital, Aalst)
Patient Involvement in Policy Making - pharma.be II
Chair : Xavier De Cuyper (CEO FAMHP)
- "Patient involvement: a new challenge for the industry" - Magali Geens (Research Director InSites Consulting)
- "Patient Involvement improves Health Care Policy Outcomes" - Dr. Markus Breuer (Head of Education Institute Dialogue Ethics – Interdisciplinary Institute for ethics in health care in Zurich (CH))
16:00 - 16:45
Coffee break - Exhibition Lounge
16:45 – 18:00
pharma / health care and the ECONOSHOCK - Plenary Room
Chair : Tom Heyman (CEO Janssen Pharmaceutica N.V. in Belgium)
- "Research Based Pharma Companies in Austerity Times" - Dr. Bruno Strigini (President Europe/Canada, Merck & Co., Inc./MSD)
- "The Pharma Sector after the Econoshock" - Geert Noels (Chief Economist & CEO Econopolis)
18:00 – 19:00
30 years Galenus – Award Ceremony – Plenary Room
In association with Artsenkrant / Le Journal du médecin
![]() |
![]() |
Chair : Prof. Dr. Leo Neels (CEO pharma.be)
- "Opening address and Award Ceremony" - Prime Minister Elio Di Rupo
- "Presentation of the jury’s conclusions concerning the award winning innovative medicine" - Prof. Jean-Marc Kaufman (Full professor and chair of the department of Internal Medicine Ghent University and Chair of Endocrinology and Laboratory for Hormonology Ghent University Hospital)
- Presentation by the award winning company
- Presentation by a member of the Galenus jury of the Award winning young scientist
- "30 jaar jury-werking Belgische Galenus prijs – 30 ans de jury prix Gallien Belge" – Prof. Em. Dr. Arnold G. Herman
19:00 – 20:30
Cocktail & networking – Exhibition Lounge



